Fresh analysis indicates that individuals who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who end conventional diet and exercise regimens.
Published data in a leading medical journal points out that while overweight people can lose a large proportion of their total mass while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Users using these drugs should be cognizant of the potential of rapid weight regain when the medication ends," warns expert Dr. Susan Jebb.
This pace of regain implies a reversion to starting mass in about 18 months.
Analyzing Approaches
The analysis, which examined 37 of trials involving thousands of patients, contrasted the outcomes of these new drugs with older methods.
Scientists point out that people who lose weight through diet and exercise usually experience a less rapid weight regain—perhaps 100 grams monthly—after stopping.
Understanding the Quick Rebound
Doctors suggest the mechanism of the injections explains the amplified rebound.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations far above than normal might result in the body to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' leads to hunger is uncontrolled, making binge eating far more likely."
An Ongoing Condition?
Medical guidelines advise the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals argue that, due to the high risk of weight regain, the therapy is often long-term.
This opinion is echoed by drug manufacturers, who state that the findings "highlight the chronic nature of excess weight," akin to managing conditions like hypertension.
User Experiences
People who have stopped the medication explain a sudden return of cravings.
"It felt as if a switch activating and I was suddenly starving," said a patient.
This challenge is worsened if individuals have not developed lasting lifestyle or habit changes during therapy.
Significant Adoption
Survey data indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.
- Adoption is greater among females than men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
In conclusion, researchers caution that while GLP-1 drugs are effective agents for weight loss, they are not a magic fix and lasting health benefits relies on ongoing lifestyle support.
